The stock price of Mylan is soaring,but the pharmaceutical company might not be out of the woods yet. After a summer of corrupt headlines, Congressional testimony, or agreements to pay back millions to the government,the Pentagon is looking at how much Mylan has been overcharging since 2008.
Read more...
Source: gawker.com